bf/NYSE:BSX_icon.jpeg

NYSE:BSX

Boston Scientific Corporation

  • Stock

USD

Last Close

72.03

03/05 20:00

Market Cap

89.55B

Beta: 0.80

Volume Today

7.45M

Avg: 8.81M

PE Ratio

77.02

PFCF: 58.40

Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
890.50M
-
921.50M
3.48%
981M
6.46%
985.50M
0.46%
1.02B
3.15%
1.12B
10.38%
1.37B
22.33%
1.47B
6.74%
1.48B
1.06%
1.74B
17.43%
2.18B
25.14%
average payables
239M
-
254M
6.28%
235.50M
7.28%
328M
39.28%
488.50M
48.93%
439.50M
10.03%
445.50M
1.37%
527.50M
18.41%
653.50M
23.89%
828M
26.70%
902M
8.94%
average receivables
1.26B
-
1.25B
1.35%
1.23B
1.29%
1.37B
11.76%
1.51B
9.94%
1.58B
4.50%
1.77B
12.20%
1.73B
2.17%
1.65B
4.47%
1.87B
13.27%
2.10B
12.01%
book value per share
4.88
-
5.17
5.98%
4.71
8.81%
4.96
5.25%
5.12
3.18%
6.32
23.47%
9.97
57.85%
10.82
8.48%
11.69
8.03%
12.29
5.11%
13.17
7.24%
capex per share
-0.18
-
-0.20
7.06%
-0.18
5.83%
-0.28
50.39%
-0.23
15.93%
-0.23
1.72%
-0.33
44.79%
-0.27
19.89%
-0.39
46.76%
-0.43
9.84%
-0.55
27.77%
capex to depreciation
-0.36
-
-0.36
0.47%
-0.32
10.09%
-0.46
43.63%
-0.38
18.07%
-0.35
6.48%
-0.46
29.00%
-0.33
26.57%
-0.51
51.38%
-0.54
6.29%
-0.67
24.16%
capex to operating cash flow
-0.23
-
-0.20
9.86%
-0.41
101.70%
-0.39
6.03%
-0.22
42.17%
-1.02
355.67%
-0.25
75.37%
-0.25
0.70%
-0.30
18.82%
-0.40
35.37%
-0.32
20.30%
capex to revenue
-0.03
-
-0.04
2.32%
-0.03
5.87%
-0.04
35.73%
-0.04
21.37%
-0.03
8.76%
-0.04
33.49%
-0.04
11.67%
-0.05
22.86%
-0.05
3.55%
-0.06
16.42%
cash per share
0.16
-
0.44
173.96%
0.24
46.34%
0.14
39.30%
0.14
4.96%
0.11
22.95%
0.16
47.51%
1.22
684.86%
1.35
10.58%
0.65
52.07%
0.59
8.89%
days of inventory on hand
141.49
-
148.77
5.14%
165.33
11.13%
139.26
15.77%
147.87
6.18%
147.62
0.17%
181.18
22.73%
140.49
22.46%
156.29
11.25%
170.24
8.92%
208.67
22.58%
days payables outstanding
38.80
-
41.20
6.18%
34.01
17.45%
65.18
91.66%
72.70
11.53%
44.18
39.22%
62.19
40.75%
53.35
14.22%
77.08
44.48%
78.60
1.97%
79.13
0.68%
days sales outstanding
66.79
-
58.51
12.39%
62.24
6.38%
64.07
2.94%
62.45
2.53%
59.75
4.32%
65.72
10.00%
56.37
14.23%
54.59
3.16%
56.70
3.86%
57.11
0.72%
debt to assets
0.25
-
0.25
0.05%
0.31
23.63%
0.30
3.20%
0.29
3.33%
0.33
14.28%
0.34
0.43%
0.31
7.82%
0.29
5.39%
0.29
2.51%
0.27
5.50%
debt to equity
0.65
-
0.62
3.95%
0.90
44.22%
0.81
9.33%
0.80
2.32%
0.81
1.27%
0.74
8.09%
0.62
15.96%
0.57
8.65%
0.53
7.10%
0.49
6.79%
dividend yield
0.11
-
0.04
60.82%
0.00
-
0.00
65.58%
0.00
8.72%
0.00
60.17%
earnings yield
-0.01
-
0.02
302.73%
-0.01
163.51%
0.01
222.28%
0.00
74.09%
0.03
1,018.18%
0.07
118.16%
-0.00
103.68%
0.02
726.79%
0.01
38.79%
0.02
78.55%
enterprise value
20.14B
-
21.22B
5.35%
30.09B
41.79%
34.65B
15.17%
39.35B
13.57%
55.69B
41.50%
72.98B
31.06%
58.74B
19.52%
67.95B
15.68%
74.54B
9.71%
93.23B
25.07%
enterprise value over ebitda
15.80
-
15.74
0.35%
20.81
32.18%
18.97
8.85%
19.95
5.16%
23.06
15.61%
35.05
52.02%
32.04
8.59%
24.41
23.84%
26.62
9.08%
25.75
3.26%
ev to operating cash flow
18.62
-
16.72
10.17%
50.15
199.88%
35.65
28.91%
27.60
22.59%
179.64
550.92%
39.75
77.87%
38.95
2.02%
36.33
6.71%
48.85
34.44%
37.25
23.75%
ev to sales
2.82
-
2.88
1.97%
4.02
39.95%
4.13
2.68%
4.35
5.26%
5.67
30.34%
6.80
19.92%
5.93
12.85%
5.72
3.54%
5.88
2.84%
6.55
11.39%
free cash flow per share
0.62
-
0.76
22.21%
0.26
65.49%
0.44
66.80%
0.81
84.04%
-0.00
100.54%
0.99
22,843.74%
0.80
19.14%
0.93
15.80%
0.64
30.95%
1.16
82.12%
free cash flow yield
0.05
-
0.06
10.86%
0.01
75.20%
0.02
42.20%
0.03
60.58%
-0.00
100.38%
0.02
17,874.52%
0.02
1.71%
0.02
2.00%
0.01
36.60%
0.02
45.77%
graham net net
-6.37
-
-6.07
4.76%
-7.48
23.18%
-7.06
5.58%
-7.40
4.84%
-7.49
1.13%
-10.23
36.63%
-8.40
17.92%
-8.12
3.32%
-8.08
0.46%
-8.08
0.04%
graham number
3.15
-
4.84
53.90%
4.35
10.22%
5.34
22.87%
2.96
44.64%
13.12
343.63%
27.53
109.91%
4.90
82.18%
13.87
182.86%
11.61
16.29%
17.96
54.67%
income quality
-8.94
-
-10.66
19.25%
-2.51
76.46%
2.80
211.58%
13.71
389.50%
0.19
98.65%
0.39
110.57%
-18.39
4,807.74%
1.80
109.77%
2.19
21.70%
1.57
28.09%
intangibles to total assets
0.70
-
0.68
1.76%
0.70
2.20%
0.69
0.63%
0.67
2.89%
0.68
0.91%
0.59
13.12%
0.52
12.76%
0.56
8.98%
0.58
3.18%
0.58
0.11%
interest coverage
0.37
-
1.38
273.75%
-1.15
183.18%
1.92
266.62%
5.61
192.49%
6.25
11.36%
3.21
48.64%
2.89
9.89%
5.99
107.17%
3.51
41.44%
8.84
152.00%
interest debt per share
3.40
-
3.38
0.63%
4.44
31.44%
4.21
5.25%
4.24
0.65%
5.27
24.22%
7.73
46.73%
6.99
9.55%
6.88
1.48%
6.82
0.98%
6.67
2.20%
inventory turnover
2.58
-
2.45
4.89%
2.21
10.02%
2.62
18.72%
2.47
5.82%
2.47
0.17%
2.01
18.52%
2.60
28.96%
2.34
10.11%
2.14
8.19%
1.75
18.42%
invested capital
0.65
-
0.62
3.95%
0.90
44.22%
0.81
9.33%
0.80
2.32%
0.81
1.27%
0.74
8.09%
0.62
15.96%
0.57
8.65%
0.53
7.10%
0.49
6.79%
market cap
16.12B
-
17.55B
8.84%
24.73B
40.95%
29.36B
18.73%
33.96B
15.66%
48.80B
43.69%
62.92B
28.93%
50.93B
19.06%
60.42B
18.63%
66.19B
9.55%
84.60B
27.82%
net current asset value
-7.02B
-
-6.59B
6.11%
-8.34B
26.53%
-8.12B
2.61%
-8.21B
1.03%
-8.27B
0.76%
-11.99B
44.97%
-8.76B
26.96%
-9.29B
6.09%
-9.14B
1.66%
-9.09B
0.48%
net debt to ebitda
3.16
-
2.73
13.60%
3.71
35.91%
2.89
21.89%
2.73
5.61%
2.85
4.34%
4.83
69.51%
4.26
11.88%
2.70
36.51%
2.98
10.37%
2.38
20.12%
net income per share
-0.09
-
0.20
323.48%
-0.18
188.39%
0.26
243.43%
0.08
70.30%
1.21
1,494.05%
3.38
179.15%
-0.10
102.93%
0.73
840.64%
0.49
33.33%
1.09
123.08%
operating cash flow per share
0.81
-
0.96
18.78%
0.45
53.31%
0.72
60.04%
1.04
45.37%
0.22
78.43%
1.32
487.79%
1.06
19.33%
1.31
23.52%
1.07
18.86%
1.71
60.33%
payables turnover
9.41
-
8.86
5.82%
10.73
21.15%
5.60
47.82%
5.02
10.34%
8.26
64.53%
5.87
28.95%
6.84
16.58%
4.74
30.79%
4.64
1.94%
4.61
0.67%
receivables turnover
5.47
-
6.24
14.15%
5.86
6.00%
5.70
2.85%
5.84
2.60%
6.11
4.51%
5.55
9.09%
6.47
16.59%
6.69
3.26%
6.44
3.72%
6.39
0.72%
research and ddevelopement to revenue
0.12
-
0.11
8.16%
0.12
5.83%
0.11
6.36%
0.11
0.44%
0.11
2.83%
0.11
3.48%
0.12
5.43%
0.10
12.16%
0.10
3.00%
0.10
4.82%
return on tangible assets
-0.02
-
0.05
310.92%
-0.04
187.22%
0.06
243.38%
0.02
73.27%
0.25
1,384.94%
0.38
51.06%
-0.01
102.50%
0.07
885.11%
0.05
30.62%
0.11
111.21%
revenue per share
5.33
-
5.57
4.64%
5.57
0.04%
6.18
10.80%
6.60
6.91%
7.11
7.71%
7.71
8.46%
7.00
9.30%
8.36
19.45%
8.87
6.07%
9.73
9.75%
roe
-0.02
-
0.04
310.86%
-0.04
196.92%
0.05
236.28%
0.01
71.22%
0.19
1,191.09%
0.34
76.84%
-0.01
102.70%
0.06
785.60%
0.04
36.58%
0.08
108.02%
roic
0.01
-
0.08
1,207.79%
-0.01
112.69%
0.07
815.71%
0.01
83.99%
0.11
877.54%
0.42
278.50%
0.04
90.14%
0.07
78.02%
0.04
50.30%
0.06
73.76%
sales general and administrative to revenue
0.37
-
0.39
5.04%
0.38
2.28%
0.37
3.83%
0.36
1.48%
0.36
0.20%
shareholders equity per share
4.88
-
5.17
5.98%
4.71
8.81%
4.96
5.25%
5.12
3.18%
6.32
23.47%
9.97
57.85%
10.82
8.48%
11.69
8.03%
12.29
5.11%
13.17
7.24%
stock based compensation to revenue
0.01
-
0.01
5.05%
0.01
2.54%
0.01
3.34%
0.01
1.47%
0.01
1.54%
0.01
2.62%
0.02
17.26%
0.02
4.84%
0.02
6.30%
0.02
5.68%
tangible asset value
-5.10B
-
-4.66B
8.68%
-6.35B
36.17%
-5.83B
8.18%
-5.82B
0.07%
-5.56B
4.57%
-4.18B
24.70%
-540M
87.10%
-1.49B
175%
-1.25B
15.89%
-860M
31.14%
tangible book value per share
-3.81
-
-3.52
7.51%
-4.73
34.46%
-4.29
9.29%
-4.25
0.98%
-4.02
5.32%
-3.01
25.27%
-0.38
87.33%
-1.04
173.92%
-0.87
16.37%
-0.59
32.70%
working capital
1.35B
-
1.15B
14.90%
1.04B
9.32%
-348M
133.43%
-1.83B
426.44%
-1.26B
31.39%
-167M
86.71%
3.01B
1,904.19%
2.04B
32.19%
1.96B
4.21%
1.58B
19.21%

All numbers in USD (except ratios and percentages)